The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

NCT03889626 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

242

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasms
Gastrointestinal Neoplasms
Stomach Diseases
Digestive System Neoplasms
Capecitabine
Apatinib
Neoplasms
Molecular Mechanisms of Pharmacological Action

Interventions

DRUG: Apatinib
DRUG: Capecitabine

Sponsor

Fudan University